Showing 4831-4840 of 5623 results for "".
- Scientists Rescue ‘Mini Retinas’ From Eye Disease Via New Gene Therapy Approachhttps://modernod.com/news/scientists-rescue-mini-retinas-from-eye-disease-via-new-gene-therapy-approach/2477895/Scientists have developed a new gene therapy approach that offers promise for one day treating retinitis pigmentosa, according to Trinity College Dublin. Researchers from Trinity College and University College London (UCL) teamed up to pool their expertise in ge
- Orbis International Launches Virtual Flying Eye Hospital Training Programshttps://modernod.com/news/orbis-international-launches-virtual-flying-eye-hospital-training-programs/2477894/Orbis International launched virtual Flying Eye Hospital training programs through its telemedicine platform, Cybersight, which provides online training and mentorship for eye care professionals in low- and middle-income countries. The inaugural program has been designed for eye care professional
- Coopervision Global Charity Releases its Annual Impact Report Highlighting Achievementshttps://modernod.com/news/coopervision-global-charity-releases-its-annual-impact-report-highlighting-achievements/2479515/As pediatric myopia increases globally in prevalence and severity, CooperVision remains committed to supporting programs such as “Our Children’s Vision” implemented by the Brien Holden Foundation that prioritize children’s eye health. Over the last 3 years, CooperVision has donated a
- Here Are the Specialties Hit Hardest by the COVID-19 Pandemichttps://modernod.com/news/here-are-the-specialties-hit-hardest-by-the-covid-19-pandemic/2479516/Health care revenue fell by nearly 50% in March and April for specialties that include primary care, oral surgery, dermatology and cardiology, a new study found, according to a FierceHealthcare
- Iveric Bio Announces Positive Zimura 18 Month Data Supporting the 12 Month Efficacy Findings for GA Secondary to AMDhttps://modernod.com/news/iveric-bio-announces-positive-zimura-18-month-data-supporting-the-12-month-efficacy-findings/2479517/Iveric bio announced positive 18 month results from the company’s first phase 3 clinical trial for Zimura (avacincaptad pegol), a novel complement C5 inhibitor, for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The 18 month data support
- ProQR Announces Expert Perspectives Conference Call Serieshttps://modernod.com/news/proqr-announces-expert-perspectives-conference-call-series/2479518/ProQR Therapeutics, a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, announced that it will launch a series of Expert Perspectives calls to provide an in-depth review of topics related to the company’s pipeline and
- Oxford Biomedica Snags Manufacturing Equipment to Ramp Up Production of COVID-19 Vaccinehttps://modernod.com/news/oxford-biomedica-snags-manufacturing-equipment-to-ramp-up-production-of-covid-19-vaccine/2477880/In the race for a COVID-19 vaccine, the University of Oxford has stormed to an early lead with the commercial manufacturing support of British drugmaker AstraZeneca. Now, in an effort to scale up capacity for global demand, one of AstraZeneca’s manufacturing partners has struck a deal for n
- Market Scope: Premium IOL Volume Faces Challenges in Rebounding Post-COVIDhttps://modernod.com/news/market-scope-premium-iol-volume-faces-challenges-in-rebounding-post-covid/2477871/Results from Part 1 of Market Scope’s “COVID-19 US Practice Impact Survey” reveal that nearly 41 percent of surgeons expect a decrease in premium IOL conversion once COVID-19 subsides. These surgeons expect an average decrease of 34 percent, and most respondents believe that financial
- HHS Requiring Labs to Report Patients’ Race, Ethnicity With COVID-19 Tests in Effort to Combat Disparitieshttps://modernod.com/news/hhs-requiring-labs-to-report-patients-race-ethnicity-with-covid-19-tests-in-effort-to-combat-disparities/2477867/Following outcries from lawmakers and the public about the lack of demographic data for COVID-19 testing, the Trump administration is now requiring laboratories to collect demographic data like race, ethnicity, and sex when reporting test results, according to a FierceHealthcare
- The Lancet Withdraws Major Hydroxychloroquine Studyhttps://modernod.com/news/the-lancet-withdraws-controversial-hydroxychloroquine-study/2477866/A major study in the Lancet that suggested hydroxychloroquine was associated with higher rates of ventricular arrhythmia and death in COVID-19 patients has been retracted. The multinational registry analysis, published in the Lancet on May 22, included nearly 15,000 peopl